Situation: A nurse works in the newborn nursery and the neonatal intensive care unit (NICU) of a government hospital. She is responsible for newborn screening and for the unit's newborn screening records. A preterm infant born at 33 weeks has been in the NICU since birth and is now 4 days old and stable. Newborn screening has not yet been done. A packed red blood cell transfusion is ordered for this afternoon. What should the nurse do about the screening sample?

Two rules apply at once. Under RA 9288, infants in intensive care may have the sample collected by day 7 of life, so a 4-day-old NICU infant is still within the allowed period. The sample should also be collected before a blood transfusion, because donor blood can alter the screening results.

Clinical situation A preterm infant born at 33 weeks is now 4 days old in the NICU and stable. Newborn screening has not been done, and a packed red blood cell transfusion is scheduled for this afternoon.

Core reasoning Two rules operate together here. First, the timing rule: under RA 9288, an infant admitted to intensive care may have the screening specimen collected up to day 7 of life. A 4-day-old NICU infant is therefore still well within the allowable window, so the screening is not missed. Second, the transfusion rule: the sample must be obtained before any blood transfusion is given, because transfused donor blood can dilute or replace the infant’s own analytes and produce misleading screening results.

Why transfusion timing matters Newborn screening measures metabolites, enzymes, and endocrine markers from the infant’s own dried blood spot. When donor red blood cells are transfused, the circulating blood becomes a mixture of the infant’s blood and donor blood. Donor blood contains adult levels of many analytes and enzymes, and it also dilutes the infant’s endogenous markers. For disorders detected through enzyme activity or amino acid patterns, this can mask a true abnormality or create a false elevation. Collecting the sample before the transfusion preserves the infant’s own metabolic profile and keeps the screen valid.

The evidence supports this concern. One study examining pancreatitis-associated protein (PAP) in cystic fibrosis screening found that blood transfusion was among the variables investigated for its influence on marker concentration ^[2]. More broadly, prematurity itself alters levels of amino acids, enzymes, and endocrine markers obtained through newborn screening, which is why timing and collection conditions must be controlled carefully in preterm infants ^[3]. The AAP newborn screening fact sheets also emphasize that specimen collection conditions affect the reliability of screening results ^[1].

Watch out! Do not interpret “stable at 4 days old” as a reason to wait. Stability is not the deciding factor; the transfusion is. If the transfusion proceeds before collection, the sample may no longer reflect the infant’s own metabolic state.

Key point! For NICU infants, the collection window extends to day 7 of life, but the pre-transfusion requirement overrides any temptation to defer. When a transfusion is ordered, collect the screening sample first—even if it means doing it earlier in the day than originally planned.

Option	Clinical judgment	Why correct or incorrect
1. Report as missed	Incorrect	A NICU infant at day 4 is within the extended day-7 window under RA 9288; the screening is not late.
2. Collect today, before transfusion	Correct	Preserves the infant’s own analyte profile and stays within the allowable collection period.
3. Defer until regular nursery	Incorrect	Unnecessary delay; the infant is eligible for collection now, and waiting risks transfusion contamination or exceeding the window.
4. Collect after transfusion	Incorrect	Donor blood can alter enzyme, amino acid, and endocrine marker levels, invalidating the screen.

Nursing priority The nurse should coordinate with the NICU team to obtain the heel-prick specimen before the packed red blood cell transfusion is started, document the collection time and the infant’s NICU status, and note that the sample was collected prior to transfusion. This sequence protects the integrity of the screening result while still meeting the legal timing requirement for intensive care admissions.